ROP:SWX
Roche Holding AG Genussscheine
CHFÂ 356.80
arrow_downward
-1.22%(-4.40) 1D
Sep 18, 5:31:17 PM GMT+2 · CHF
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ROP...
Open
CHFÂ 358.60
High
CHFÂ 365.10
Low
CHFÂ 356.40
Mkt. cap
289.52B
Avg. vol.
901.87K
Volume
2.92M
Dividend
2.75%
Quarterly dividend
CHFÂ 2.45
Ex-dividend date
Mar 27, 2025
P/E ratio
23.28
52-wk high
CHFÂ 375.80
52-wk low
CHFÂ 291.00
EPS
CHFÂ 15.33
Shares outstanding
702.56M
No. of employees
113K
Open
CHFÂ 358.60
High
CHFÂ 365.10
Low
CHFÂ 356.40
Mkt. cap
289.52B
Avg. vol.
901.87K
Volume
2.92M
Dividend
2.75%
Quarterly dividend
CHFÂ 2.45
Ex-dividend date
Mar 27, 2025
P/E ratio
23.28
52-wk high
CHFÂ 375.80
52-wk low
CHFÂ 291.00
EPS
CHFÂ 15.33
Shares outstanding
702.56M
No. of employees
113K
News stories
From web sources and news partners
AD HOC NEWS
·
14 hours ago
Roche Holding stock slips after CHMP backs paediatric Ocrevus
Stock Titan
·
1 day ago
A multiple sclerosis drug for children as young as 10 moves closer to EU approval
Business Wire
·
2 days ago
Genentech and Roche Announce Grand Opening of Boston R&D Innovation Center
Stock Titan
·
2 days ago
Near Harvard, Roche opens a research center for up to 500 people
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021.
F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche Holding AG Genussscheine
CEOThomas Schinecker
Employees113K
FoundedOct 1, 1896
HeadquartersBasel, Basel City, Switzerland
SectorPharmaceutical industry
Websiteroche.com